(PharmaNewsWire.Com, November 30, 2017 ) According to the report Polymerase Chain Reaction (PCR) Market, published by Market Data Forecast, the Asia Pacific market was worth USD 1.24 billion in 2017 and estimated to be growing at a CAGR of 6.80%, to reach USD 1.73 billion by 2022.
Polymeric Chain Reaction techniques have been specifically prepared for the development in life sciences research and sub-atomic diagnosis by its highly capable elements, like Quantification of DNA and RNA and absolute recognition. Researchers can analyze and quantify rare alleles and identify mutations using highly precise PCR frameworks, like computerized PCR.
The increasing geriatric population, along with the rising incidences of chronic ailments, and technological progress in the area of life science are the major forces driving the growth of the PCR market. The growing pace of spread of infectious diseases and hereditary disorders and expansion of public private speculations, financial grants for research are also fueling the market. But, the expensive nature of dPCR equipment and technological limitations associated with qPCR and dPCR are the key factors hampering the growth of this market.
The real-time PCR segment accounted for the largest share of this segment of PCR market. This can be mainly attributed to the increasing utilization of real-time PCRs and technological advancement in the field of qPCR research.
Not only Asia pacific held the second largest share of the PCR market but also is anticipated to witness the highest CAGR in the coming years.
The Polymerase Chain Reaction (PCR) market is highly competitive with a large number of players like oche Diagnostics, Thermo Fisher Scientific, Agilent Technologies, Abbott Laboratories and Sigma-Aldrich Corporation Beckman Coulter, Becton Dickinson, Bio-Radand QIAGEN.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
